Third-party lab testing: 34 independent Janoshik assays on file, covering 22 substances, median measured purity 99.8%, most recent test 2026-02-11.
| Substance | Measured purity | Test date |
|---|---|---|
| Retatrutide | 99.43% | 2025-06-05 |
| Retatrutide | 99.28% | 2025-06-05 |
| Thymulin | 99.97% | 2024-12-16 |
| Retatrutide | 99.88% | 2024-11-11 |
| Retatrutide | 99.56% | 2024-11-11 |
| Pt-141 | 99.82% | 2024-11-11 |
| Foxo4-dri | 99.34% | 2024-11-07 |
| Survodutide | 99.88% | 2024-09-24 |
| Retatrutide | 99.91% | 2024-09-24 |
| Retatrutide | 99.61% | 2024-09-24 |
| Retatrutide | 99.82% | 2024-09-24 |
| Semaglutide | 98.27% | 2024-08-07 |
| PE 22-28 | 99.49% | 2024-06-24 |
| Semaglutide | 99.87% | 2024-06-15 |
| Melanotan | 99.89% | 2024-06-14 |
| GHK Basic | 99.77% | 2024-06-12 |
| DSIP | 99.98% | 2024-06-06 |
| Retatrutide | 99.80% | 2024-05-22 |
| Epithalon 10mg | 99.95% | 2024-04-17 |
| Mazdutide 6 Mg | 99.83% | 2024-04-05 |
| Bpc-157 5mg | 99.56% | 2024-02-29 |
| Bpc-157 10mg | 99.59% | 2024-02-29 |
| Retatrutide Sodium 10mg | 99.86% | 2024-02-29 |
| Semaglutide Sodium 5mg | 99.56% | 2024-02-29 |
| Semaglutide Sodium 2mg | 99.92% | 2024-02-29 |
| GLOW | not reported | 2026-02-11 |
| Retatrutide | not reported | 2024-11-27 |
| Retatrutide | not reported | 2024-10-07 |
| Semaglutide | not reported | 2024-08-16 |
| Semaglutide | not reported | 2024-07-25 |
| Cjc-1295 (without Dac) /ipamorelin Blend | not reported | 2024-06-26 |
| N-acetyl Semax Amidate | not reported | 2024-06-14 |
| Nad+ | not reported | 2024-06-11 |
| Glow Blend - Ghk-cu 35mg / Tb-500 10mg / Bpc-157 5mg | not reported | 2024-02-29 |
25 of these 34 assays report a measured purity figure. The other 9 confirm the substance was submitted and tested but carry no purity number on the certificate, which is not the same as a failed result.